← Back to Search

Menthol Ban for Tobacco Use

N/A
Waitlist Available
Led By William G Shadel, PhD
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up there is one visit in this research: this variable is assessed at that visit, immediately after the experimental manipulation.
Awards & highlights

Study Summary

This trial will be testing if getting rid of flavored tobacco products at stores will reduce the risk of adolescents smoking.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~there is one visit in this research: this variable is assessed at that visit, immediately after the experimental manipulation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and there is one visit in this research: this variable is assessed at that visit, immediately after the experimental manipulation. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of Participants Susceptible to Smoking Cigarettes After Shopping in the StoreLab (Menthol)
Proportion of Participants Susceptible to Smoking Cigarettes After Shopping in the StoreLab (Non-flavored)
Secondary outcome measures
Proportion of Participants Susceptible to Using Electronic Nicotine Delivery Device (ENDS) After Shopping in the StoreLab (Menthol-flavored)
Proportion of Participants Susceptible to Using Electronic Nicotine Delivery Device (ENDS) After Shopping in the StoreLab (Non-flavored)
Proportion of Participants Susceptible to Using Electronic Nicotine Delivery Device (ENDS) After Shopping in the StoreLab (Sweet-flavored)
+6 more

Side effects data

From 2017 Phase 3 trial • 229 Patients • NCT03095508
2%
Throat irritation
1%
Cough
1%
Oral discomfort
1%
Nausea
1%
Chest pain
1%
Gingival pain
1%
Leukocytosis
1%
Abdominal pain upper
1%
Dyspepsia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Angal S (Arm A)
ANTI-ANGIN® FORMULA (Arm B)

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Flavors and Menthol BannedExperimental Treatment2 Interventions
The StoreLab will display only tobacco products without characterizing flavors; mint and menthol will not be displayed.
Group II: Flavors BannedExperimental Treatment1 Intervention
The StoreLab will display tobacco products without characterizing flavors, but will allow mint and menthol products to be displayed.
Group III: Status QuoActive Control1 Intervention
The StoreLab power wall will display all tobacco products.

Find a Location

Who is running the clinical trial?

RANDLead Sponsor
137 Previous Clinical Trials
509,984 Total Patients Enrolled
2 Trials studying Tobacco Use
725 Patients Enrolled for Tobacco Use
William G Shadel, PhDPrincipal InvestigatorRAND

Media Library

Menthol Ban Clinical Trial Eligibility Overview. Trial Name: NCT04259749 — N/A
Tobacco Use Research Study Groups: Flavors and Menthol Banned, Flavors Banned, Status Quo
Tobacco Use Clinical Trial 2023: Menthol Ban Highlights & Side Effects. Trial Name: NCT04259749 — N/A
Menthol Ban 2023 Treatment Timeline for Medical Study. Trial Name: NCT04259749 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for this clinical research study?

"This trial is recruiting up to 900 juvenile individuals, aged 11-17, who have a history of tobacco use. To join the study, minors need parental permission and their own assent."

Answered by AI

Is the age threshold for participation in this experiment set beyond eighty-five years?

"The youngest possible participant in this clinical trial is 11 years old, while the eldest must be no older than 17."

Answered by AI

Are there any slots still available to join this experiment?

"According to the data published on clinicaltrials.gov, this investigation is presently recruiting patients. The trail was initially made available on January 16th 2020 before being revised most recently on February 14th 2022."

Answered by AI

How extensive is the patient population currently enrolled in this clinical study?

"Affirmative. The details of this trial, which were initially posted on January 16th 2020, can be found on clinicaltrials.gov and suggest that the study is actively recruiting participants. Approximately 900 individuals are being sought out at a single site for participation in the trial."

Answered by AI
~51 spots leftby Apr 2025